February 10, 2022
Toward an Endemic Covid-19 State
February 9, 2022
A Moonshot for LBx: NCI RCT Would Separate MCED Winners & Losers
February 4, 2022
Protected: Nephron Research Private Equity Panel – February 3rd
January 31, 2022
Protected: Healthcare Bull/Bear Debates to Start 2022 – Jan. 28th, 2022
January 26, 2022
Protected: KOL Views on CRC Diagnostics for Cologuard & Liquid Biopsy Post ASCO-GI – Jan. 24th, 2022
January 21, 2022
Protected: KOL Views on Genomics Innovation w/ Dr. Chris Mason at Weill Cornell – Jan. 19th, 2022
January 12, 2022
BIIB’s Aduhelm: Medicare Coverage Proposal for Alzheimer’s Drugs
December 16, 2021
Protected: Nephron Research 2022 Outlook Call Replay
December 9, 2021
Nephron’s Simpson on Durable Medical Equipment Pay Rule; CGMs
November 29, 2021
Medicare Advantage Outlook: Industry Positioned For Growth; $1T+ by 2031
November 18, 2021
Protected: Bioprocessing Update with Howard Levine – 11/17/21
November 4, 2021
Protected: China Dx Purchasing Expert Update – Mon, 11/1
October 26, 2021
Protected: The Consolidation of Digital Health: Payor Platforms + Pure Plays + Point Solutions
October 8, 2021
Nephron’s Digital Health Coverage Grows With Sharecare Initiation
October 6, 2021
Nephron Adds to Physician Enablement Coverage with CareMax Initiation